Call Spread on TXG on 12/14/2020

10x Genomics, Inc. (TXG), a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific.

Its company offers chromium instruments, enzymes, microfluidic chips, slides, reagents, and other consumable products.

The company's single cell solution runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics, including the physical organization of DNA; single cell CNV for measuring cellular heterogeneity through DNA changes, such as copy number variation; and visium spatial gene expression solution that measures the spatial gene expression patterns across a tissue sample.

It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014.

We are trading January 15th Call Spread

Last Trade: $147.95

Tradinf Range: $48.78 - $166.31

Trade Buy 1 January $150.00 Call at $7.83 Sell 1 January $160.00 Call at $4.40 For a net debit of $3.43 Profit/Loss Analysis Breakeven at $153.43 Maximum profit is $657.00 at strike of $160.00 Maximum loss is ($343.00) at strike of $150.00 Closing Summary Sold 1 January $150.00 Call at $15.00 Bought 1 January $160.00 Call at $9.00

Position closed on 12/18/2020 at price of $6.00 with a 74.93% gain in 4 days.

Updates

12/18/2020 10:05:49 AM

TXG call spread closed.

Back to Portfolio